April 29, 2026—enVVeno Medical Corporation announced it has received an FDA investigational device exemption (IDE) for the pivotal study of the ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

We value keeping the Device Guide up to date.

Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...

Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

Cagent Vascular announced the publication of data demonstrating the safety and efficacy of the company’s Serranator percuta ...

Hjarta Care announced that the FDA has granted de novo authorization for the EVAR XplantR, which is a purpose-built, ...

New codes and introductory language that became effective January 1, 2015 to describe percutaneous treatment of vertebral fractures have raised questions from users, which this article attempts to ...

Angiolutions announced the appointment of four internationally recognized vascular and endovascular specialists to its ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.